|
|
Tuesday,
July 27, 2010
8:00 -
13:00 |
|
Board No. |
|
POSTER HALL |
|
P501
Poster
Session
NUCLEAR CARDIOLOGY/ POSITRON EMISSION TOMOGRAPHY/ CARDIAC
CT AND MRI
|
|
1 |
EVALUATION OF CORONARY ARTERY DISEASE COMPLICATED BY THORACIC AORTIC DISEASE BY WIDE-VOLUME SCAN USING 320-ROW CT
K. Morishige, T. Yamawaki, H. Tashiro, St. Mary's Hospital, Kurume, Japan |
|
2 |
RELATION OF LEFT ATRIAL BODY AND LEFT ATRIAL APPENDAGE VOLUMES WITH CLINICAL PATTERN OF AF
S. Verma, E. Charaf, N. Garg, Cardiology Consultants, Pensacola, FL, USA |
|
3 |
IS IT SAFE TO USE REGADENOSON FOR PHARMACOLOGIC STRESS MYCOCARDIAL PERFUSION IMAGING IN END STAGE RENAL DISEASE PATIENTS ON DIALYSIS? FIRST CLINICAL REPORT OF 12 PATIENTS
Z. Husain, G. Palani, A. Karthikeyan, V. Karthikeyan,
K. Ananthasubramaniam
St Joseph Mercy Oakland, Pontiac, MI, USA |
|
4 |
CT ANGIOGRAPHY AND AORTIC ARCH ATHEROSCLEROSIS
D.J. Capampangan, A. Patel, S.J. Lester, L.A. Pearce, B.M. Demaerschalk,
D.W. Dodick, T.E. Kiernan,
T.J. Ingall, M.I. Aguilar, Mayo Clinic, Phoenix, AZ, USA |
|
5 |
DOES PERIPROCEDURAL MYONECROSIS AFTER MAIN VESSEL STENTING OF CORONARY BIFURCATIONS OCCUR? ASSESSMENT BY MEANS OF MRI DELAYED ENHANCEMENT
A. Michalek, D.I. Vassilev, R.J. Gil, T. Pawlowski,
T. Kulawik
Central Hospital of the Internal Affairs and Adminstration Ministry, Poland |
|
|
|
|
|
P502
Poster Session
ACUTE MYOCARDIAL INFARCTION / REPERFUSION THERAPY |
|
6 |
EFFECT OF EARLIER DOOR TO BALLOON TIMES ON USE OF ADJUNCTIVE MEDICATIONS, AND RESULTANT PROCEDURAL SUCCESS IN STEMI
J.R. Cook, L.W. Klein, J. Chow, R. Marok, P.J. Stecy,
K. Magurany,
Illinois Masonic Medical Center, Chicago, IL, USA |
|
7 |
MECHANISM OF ELECTRICAL STIMULATION-INDUCED PRE- AND POST-CONDITIONING
X. Ren, Y. Liu, M. Tranter, M. Wilhide, T. Forde, L. Haar, K. Jones
University of Cincinnati, OH, USA |
|
8 |
THROMBUS ASPIRATION IN AMI PATIENTS AFTER SYSTEMIC TLT COMBINED WITH EMERGENCY PCI
D.G. Iosseliani, A.G. Koledinsky, D.G. Gromov,
N.V. Kuchkina, R.V. Zeynalov
Moscow City Center of Interventional Cardioangiology, Moscow, Russia |
|
9 |
NEIGHBORHOOD VARIATION IN RATE OF REVASCULARIZATION AMONG ACUTE MYOCARDIAL INFARCTION PATIENTS IN NEW YORK CITY
A. Negassa, Albert Einstein College of Medicine, Bronx, NY, USA |
|
|
|
|
|
P503
Poster Session
INTERVENTIONAL CARDIOLOGY II |
|
10 |
PREDICTORS OF CORONARY INTERVENTION-RELATED MYOCARDIAL INFARCTION IN STABLE ANGINA PATIENTS PRETREATED WITH STATINS
J. Veselka, P. Hajek, M. Maly, D. Zemanek, R. Adlova, D. Tesar, L. Martinkovicova,
P. Tomasov, CardioVascular Center, University Hospital Motol, Prague,
Czech Republic |
|
11 |
OUTCOMES OF PCI IN NONAGENARIANS
C.N. Ionescu, M. Amuchastegui, S.C. Ionescu,
C.B. Marcu, A. Ghantous, S. Reddy,
Hospital of Saint Raphael, New Haven, CT, USA |
|
12 |
CLINICAL AND ELECTROCARDIOGRAPHIC CORRELATES OF NORMAL CORONARY ANGIOGRAPHY IN PATIENTS REFERED FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTION
S.B. Prasad, D.A. Richards, N. Sadick, A.T. Ong,
A. Narayan, P. Kovoor
Westmead Hospital, Sydney, Australia |
|
13 |
IMPACT OF RISK FACTORS ON VASCULAR COMPLICATIONS AFTER PRECUTANEOUS CORONARY INTERVENTIONS IN SHAHEED RAJAEE HEART CENTER
A.A. Yusefi, H. Farshidi, M. Madani, F. Shakeryan,
H.R. Sanati, A. Firoozi,
N. Salehi, Hormozgan University, Bandar Abbass, Hormozgan, Iran |
|
14 |
THE FACTORS ASSOCIATED WITH STENOSIS DEGREE IN CORONARY BIFURCATIONS INFLUENCE RESTENOSIS RATES AFTER SINGLE STENT IMPLANTATION IN CORONARY BIFURCATION LESIONS
D.I. Vassilev, R.J. Gil, A. Michalek, T. Kulawik,
T. Pawlowski
Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland |
|
15 |
LONG-TERM FOLLOW UP OF PATIENTS TREATED WITH PACLITAXEL-ELUTING STENTS WITH BIOSTABLE POLYMER VERSUS BIORESORBABLE POLYMER
L.A. Inigo-Garcia, C. Medina-Palomo, T. Gil-Jimenez,
O. Sanz-Vazquez,
M. Pombo-Jimenez,
J.F. Munoz-Bellido, P. Chinchurreta-Capote,
B. Zaya-Ganfornina, J.R. Siles-Rubio, F. Ruiz-Mateas, Hospital Costa del Sol. Marbella, MA, Spain |
|
|
|
|
|
P504
Poster Session
DIABETES MELLITUS, THE METABOLIC SYNDROME AND
ATHEROSCLEROSIS: BASIC AND CLINICAL II
|
|
16 |
THE EFFECT OF INSULIN ON INTRACELLULAR NA+ HOMEOSTASIS IN ISOLATED CARDIOMYOCYTES FROM DIABETIC RATS
A. Bilginoglu, H.B. Kandilci, B. Turan, Ankara University, Ankara, Turkey |
|
17 |
ASSOCIATION OF ADIPONECTIN AND THE HYPERTRIGLYCERIDEMIC-WAIST PHENOTYPE WITH IMPAIRED GLUCOSE TOLERANCE IN WOMEN
J. Methot, Y. Loucif, D. Brisson, D. Gaudet, Université de Montréal, Montréal, Canada |
|
18 |
RELATIONSHIP BETWEEN SLEEP QUALITY AND METABOLIC SYNDROME AND INFLAMMATORY MARKERS IN MIDDLE-AGED MEN IN KOREA
J.H. Cho, S.G. Kang, E.J. Lee, S.W. Song,
St.Vincent's Hospital, The Catholic University of Korea, Suwon, Gyeonggido,
South Korea |
|
19 |
ERYTHROCYTE FRAGILITY IS INCREASED IN THE LDL RECEPTOR DEFICIENT MOUSE MODEL
K. Navab, S. Hama, G. Hough, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA |
|
20 |
EFFECT OF THERAPEUTIC LIFESTYLE CHANGE ON HIGH DENSITY
LIPOPROTEIN CHOLESTEROL IN PATIENTS WITH METABOLIC
SYNDROME
S.H. Kim, H.L. Lee, J.B. Seo, W.Y. Chung, J.H. Zo,
M.A. Kim,
Seoul Metropolitan Boramae Hospital, Seoul National University, Seoul National
University Hospital, Seoul, Korea |
|
21 |
CARDIOVASCULAR HEALTH PROFILE OF PATIENTS ENROLLED IN A CLINIC BASED DIABETES PREVENTION PROGRAM
F.D. Fortuin, C. Kendall, J. Wisbey, R.T. Hurst,
S.J. Lester, S.B. Chism,
R. Burke, M. Orban, S. Bersoux, C. Cook, Mayo Clinic Arizona, Phoenix, AZ, USA |
|
22 |
GENDER AND INFLAMMATION IN INDIVIDUALS WITH THE
METABOLIC SYNDROME
I. Shapira, S. Berliner, O. Rogowski,
Tel Aviv Sourasky Medical Center, Tel Aviv, Sackler Faculty of Medicine,
Tel Aviv University, Tel Aviv, Israel |
|
|
|
|
|
P505 Poster Session
LIPID, LIPOPROTEIN DISORDERS AND CAD/ TREATMENT OF
DYSLIPOPROTEINEMIA II
|
|
23 |
EXPERIMENTS ON THE MECHANISM OF FORMATION OF THE FATTY ACID HYDROPEROXIDES (HPODE AND HPETE)
D. Golchian, G. Hough, L. Vakili, S. Safarpoor, S. Hama
David Geffen School of Medicine, University of California Los Angeles,
Los Angeles, CA, USA |
|
24 |
EFFICACY ON LIPOPROTEIN PROFILE AND TOLERABILITY OF
SUSTAINED RELEASE FORMULATION OF SIMVASTATIN; IS THERE ANY
DIFFERENCE BETWEEN MORNING INTAKE OR NIGHTTIME GROUP?
S.H. Kim, H.Y. Lee, J.B. Seo, J.H. Zo, M.A. Kim,
Seoul Metropolitan Boramae Hospital, Seoul Metropolitan Bukbu Geriatric
Hospital, Seoul National University, Seoul, Korea |
|
25 |
ANTI-INFLAMMATORY PEPTIDE COMBINATION ADDITIVELY RENDERS CARDIOMYOPATHY PATIENT PLASMA ANTI-INFLAMMATORY
O. Elboudwarej, J.B. Kim, S. Hama, G. Hough,
G. Fonarow
David Geffen School of Medicine, Los Angeles, CA, USA |
|
26 |
ACUTE REDUCTION OF LIPOPROTEIN A FOLLOWING LDL- APHERESIS MAY IMPROVE SYMPTOMS OF ANGINA
D.G. Bulchandani, P. Moriarty, University of Kansas School of Medicine,
Kansas City, KS, USA |
|
51 |
EFFECT OF EVERY OTHER DAY VERSUS DAILY DOSING OF ATORVASTATIN ON C-REACTIVE PROTEIN AND LIPID PROFILE
O.A. Rifaie, W.M. Nammas, A.M. Zahran, Ainshams University, Egypt |
|
|
|
|
|
P506 Poster Session
DILATED CARDIOMYOPATHIES: VARIOUS ETIOLOGIES |
|
27 |
THE DETERMINANTS OF RIGHT VENTRICULAR FAILURE IN PATIENTS ADMITTED WITH ACUTE RIGHT HEART FAILURE
R.B. Berkowitz, E. Alhaj, K. Satya, R.B. Manchikalapudi, S. Dadfarmay, Hackensack University Medical Center, Hackensack, NJ, USA |
|
28 |
CEREBRAL HEMORRHAGE; PRECIPITATING EVENT FOR A TAKO-TSUBO-LIKE CARDIOMYOPATHY
A.R. Rahimi, M. Katayama, J. Mills, Mercer U. School of Medicine, Savannah, Georgia, USA |
|
|
|
|
|
P507 Poster Session
DRUG THERAPY IN HEART FAILURE: BASIC AND CLINICAL |
|
29 |
SSTR5 AND ß1-AR BLOCKS SST MEDIATED INHIBITION OF cAMP AND SIGNALING IN RECEPTOR SPECIFIC MANNER
R.K. Somvanshi, S.A. War, N. Chaudhari, G. Kharmate, P.S. Rajput, D. Bakshi,
X. Qiu, U. Kumar,
The University of British Columbia, Vancouver, BC, Canada |
|
30 |
MODULATION OF APOPTOTIC AND CALCINEURIN-MEDIATED NFAT DEPHOSPHORYLATION IN CELLS COEXPRESSING SSTR5 AND ß2-AR
R.K. Somvanshi, S.A. War, N. Chaudhari, G. Kharmate, P.S. Rajput, D. Bakshi,
X. Qiu, U. Kumar,
The University of British Columbia, Vancouver, BC, Canada |
|
31 |
TREATMENT WITH L-CARNITINE SIGNIFICANTLY IMPROVES DIASTOLIC HEART FAILURE AND SYMPTOMS
A.R. Serati, M.R. Motamedi, S. Emami, P. Varedi,
M.R. Movahed,
The Southern Arizona VA Health Care System, AZ, USA |
|
32 |
THIAMIN SUPPLEMENTATION IN PATIENTS WITH CHRONIC HEART FAILURE RECEIVING FULL MEDICAL TREATMENT
M. Mousavi, S. Namazi, M.R. Avadi
Khatam-al-Anbia Hospital, Iran |
|
|
|
|
|
P508 Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY: BASIC AND
CLINICAL
|
|
33 |
A STRUCTURED AMIODARONE PROTOCOL FOR THE MANAGEMENT OF POST OPERATIVE ATRIAL FIBRILLATION IS EQUIVALENT TO INDIVIDUALIZED PHYSICIAN MANAGEMENT
M.J. Shih, M.G. Parikh, A. Khandelwal, R.S.D. Higgins, K. Krishnan,
Rush University Medical Center, Chicago, IL, USA |
|
34 |
THE PREVALENCE OF INTRA-VENTRICULAR CONDUCTION DELAY IN ATRIAL FIBRILLATION
E.A. Charaf, B.S. Abi-Saleh, P. Sultani, B. Omar,
S. Verma, University of South Alabama, Mobile, Alabama, USA |
|
35 |
SLOWING HEART RATE REDUCES INCIDENCE OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION - EXPERIMENTAL STUDY
L. Katsaros, N. Diakos, I. Pozios, E. Tseliou,
K. Malliaras, C. Pantsios,
S. Sventzouri, N. Michelinakis,
J. Terrovitis, J. Nanas, University of Athens, Greece |
|
36 |
ORAL ASCORBIC ACID IS EFFECTIVE IN THE PREVENTION OF ATRIAL FIBRILLATION AFTER CORONARY ARTERY BYPASS GRAFTING
M. Mousavi, M. Eslami, R. Sattarzadeh Badkoubeh,
H. Radmehr, M. Salehi,
N. Tavakoli, M.R. Avadi, Tehran Heart Center,Tehran University of Medical Sciences, Tehran, Iran |
|
37 |
ASSOCIATION OF WARFARIN USE WITH CHADS2 SCORE IN 441 PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION AND NO CONTRAINDICATIONS TO WARFARIN
H.M. Lai, W.S. Aronow, H.V. Desai, K. Gandhi,
S. Bakerywala, J. Laimuanpuii,
M. Sharma, S.J. Peterson, New York Medical College, Valhalla, NY, USA |
|
38 |
MULTIFACTORIAL QT INTERVAL PROLONGATION: THE RISK OF POLYPHARMACY
G.C. Digby, A.R. Perez Riera, R. Barbosa Barros,
L. de Sousa Belem, C. Fong,
M. Methot, F. Femenia,
A. Baranchuk
Department of Cardiology, Kingston General Hospital, Queen's University, Kingston, ON, Canada |
|
39 |
WHAT ARE THE RISK FACTORS FOR DEVELOPING ATRIAL FIBRILLATION IN HIV INFECTED PATIENTS?
Y. Elnahar, J. Daoko, N. Gupta, F. Shamoon,
A. Al-dehneh, Seton Hall University, Newark,
NJ, USA |
|
|
|
|
|
P509 Poster Session
ADVANCES IN CARDIAC SURGERY |
|
40 |
SELECTIVE MITOCHONDRIAL TRANSLOCATION OF PHOSPHORYLATED PKCÅ IN VIABLE MYOCYTES OVEREXPRESSING UROCORTIN AFTER CARDIOPLEGIC ARREST AND REPERFUSION
C. Chen-Scarabelli, S. Saravolatz, L.D. Saravolatz II,
G.M. Scarabelli, G. Chen,
J. Di Rezze, L. Saravolatz,
T.M. Scarabelli, St John Hospital, Wayne State University, Detroit, MI, USA |
|
41 |
COMPARISON OF CORONARY ARTERY BYPASS GRAFTING VERSUS DRUG-ELUTING IMPLANTATION
P.P. Pollice, S.E. Saad, P.F. Pollice, F.A. Fabiani,
University of Berne, Switzerland |
|
42 |
LOWER TREND IN THE NATIONWIDE IN-HOSPITAL MORTALITY OF PATIENTS UNDERGOING CORONARY BYPASS SURGERY (CABG) IN THE UNITED STATES
M.R. Movahed, R.Ramaraj, M. Hashemzadeh, University of Arizona Sarver Heart Center, Tucson, AR, USA |
|
43 |
CAROTID INTIMA-MEDIA THICKNESS BY B-MODE ULTRASOUND AS SURROGATE OF CORONARY ATHEROSCLEROSIS
M. Amato, P. Montorsi, A.L. Ravani, S. Galli,
P.M. Ravagnani, E. Tremoli,
D. Baldassarre, Monzino Cardiology Center, IRCCS, Italy |
|
44 |
PREVIOUS PERCUTANEUS CORONARY STENTING: A NEW RISK FACTOR IN CARDIAC SURGERY
J. Rubio, J. Sierra, L. Reija, B. Adrio, J. Garcia-Carro, J.M. Martinez-Cereijo,
C. Delgado, Universitary Hospital Santiago de Compostela, Santiagio de Compostela, Spain |
|
45 |
EFFECT OF CABG ON QT INTERVAL DISPERSION AS A MEASURE OF INHOMOGENEITY IN VENTRICULAR REPOLARIZATION
M. Nourizadeh, M. Alasti, S. Bahadoran,
M. Asadmoghadam
Department of Cardiology, Imam Khomeini Hospital, Jondishapour University of Medical Sciences, Ahwaz, Iran |
|
46 |
REVASCULARIZATION OUTCOMES ON THE JOINT CARDIOLOGY-CARDIOTHORACIC MULTIDISCIPLINARY TEAM (MDT) MEETING
W.K. Choo, R.A. Amersey, Whipps Cross University Hospital, London, UK |
|
47 |
ASSESSMENT OF KIDNEY FUNCTION BY CYSTATIN C IN PATIENTS, AFTER CORONARY ARTERY BYPASS GRAFTING
M. Ster, T. Pintar, M. Tesovnik, J. Osredkar, M. Skitek,
University Medical Centre, Ljubljana, Slovenia |
|
|
|
|
|
P510 Poster Session
CARDIAC TRANSPLANTATION |
|
48 |
THE USE OF IVUS FOR DIAGNOSIS AND MONITORING OF CARDIAC ALLOGRAFT VASCULOPATHY BY CARDIAC TRANSPLANT CENTERS IN THE UNITED STATES
E. Panczyk, J.C. Copeland, M.R. Movahed, University of Arizona Sarver Heart Center, Tucson, AR, USA |
|
49 |
PROTAMINE CAN BE SAFELY ADMINISTERED FOR HEPARIN REVERSAL FOLLOWING IVUS IN CARDIAC TRANSPLANT PATIENTS
R. Arsanjani, A. Khitri, M. Hashemzadeh, M.R. Movahed,
The Southern Arizona VA Health Care System, Tucson, AZ, USA |
|
50 |
CNI - FREE IM IN CARDIAC TRANSPLANTATION - A SINGLE CENTER EXPERIENCE
M. Kondruweit, R. Tandler, M. Weyand, University of Erlangen, Bavaria, Germany |
|
|
|
|
|
|